ELEV

Elevation Oncology, Inc. ELEV

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ELEV EFTR ENVB OCEA TECX INAB UNCY TCRX HTCR
6M -39.91 % 0.00 % -50.00 % -84.14 % -0.87 % -53.95 % -18.98 % 78.23 % 25.27 %
YTD -38.67 % 19 900.00 % -89.32 % -98.84 % -64.94 % -75.03 % -43.94 % -28.48 % -70.89 %
1Y -54.38 % -99.38 % -89.89 % -99.24 % -52.53 % -69.16 % 14.73 % -60.18 % -12.04 %
3Y -70.80 % -100.00 % -98.88 % -99.93 % 122.50 % -96.37 % -23.45 % -21.91 % -14.76 %
5Y -96.81 % -100.00 % -99.98 % -99.93 % -91.18 % -99.30 % -91.12 % -78.95 % -83.30 %
10Y -96.81 % -100.00 % -100.00 % -99.93 % -95.72 % -99.30 % -91.12 % -78.95 % -83.30 %
From the beginning -96.81 % -100.00 % -100.00 % -99.93 % -95.72 % -99.30 % -91.12 % -78.95 % -83.30 %

Dividend

Enveric Biosciences, Inc.

HeartCore Enterprises, Inc.